Improving eye-drop administration skills of patients - A multicenter parallel-group cluster-randomized controlled trial

PloS One
Anette LampertHanna M Seidling

Abstract

Eye-drop administration errors occur in the majority of patients and increase the risk for treatment failure or systemic adverse events. While lacking knowledge is the principal error cause, most patients overestimate their skills and are unaware of often substantial knowledge gaps. Therefore, the impact of including motivational patient education on long-term eye-drop administration skills of patients was investigated. This is a cluster-randomized controlled trial in German community pharmacies. Patient education in both groups comprised observation of the patient during eye-drop administration to identify individual errors, pharmaceutical counseling, and teach-back evaluation of the training. In the intervention group, motivational communication techniques were included to increase error awareness and readiness for patient education. In addition, intervention patients were trained on repeated errors until administration was performed correctly. In contrast, patients in the control group only received feedback on erroneous administration steps without another assessment and reinforced training. In total, 152 adult patients were eligible to the study and 91 patients (intervention group N = 46) agreed to participate in a 1-month...Continue Reading

References

Mar 1, 1992·Drugs & Aging·P H Rivers
Aug 1, 1990·The British Journal of Ophthalmology·A J WinfieldL Esakowitz
Apr 15, 1988·American Journal of Ophthalmology·O D ScheinK R Kenyon
Jan 1, 1987·Journal of Ocular Pharmacology·F T Fraunfelder, S M Meyer
Apr 1, 1984·Archives of Ophthalmology·T J ZimmermanL P Ziegler
Jun 1, 1982·American Journal of Ophthalmology·W C TempletonM J Raff
Nov 1, 1994·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·A LoewensteinM Lazar
Jun 14, 2001·Journal of Clinical Pharmacology·M SchulzK C Bergmann
May 13, 2009·Annals of Family Medicine·Stephen BuetowGlyn Elwyn
Jun 10, 2009·Archives of Ophthalmology·Jennifer L StoneGerald D Cagle
Jul 24, 2010·Survey of Ophthalmology·Kelly W Muir, Paul P Lee
Dec 17, 2010·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Audrey Jusko FriedmanGale Turnbull
Feb 22, 2011·Journal of Glaucoma·Raghav GuptaTanuj Dada
May 18, 2012·Journal of General Internal Medicine·Valerie G PressJerry A Krishnan
Sep 7, 2012·BMJ : British Medical Journal·Marion K CampbellUNKNOWN CONSORT Group
Sep 7, 2013·Current Medical Research and Opinion·Gail F SchwartzJulia M Williams
Sep 23, 2014·Patient Education and Counseling·Anette LampertHanna M Seidling
Aug 26, 2015·The International Journal of Pharmacy Practice·Robyn SaynerBetsy Sleath
Jan 12, 2016·Health Communication·Delesha M CarpenterBetsy L Sleath
May 11, 2016·British Journal of Clinical Pharmacology·Daniel R MoralesBruce Guthrie
Aug 12, 2016·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Anette LampertHanna M Seidling

❮ Previous
Next ❯

Citations

Jan 17, 2020·Ocular Immunology and Inflammation·Hedayat JavidiPhilip I Murray
May 29, 2021·Journal of Glaucoma·Catherine Q ZhuManishi Desai
Sep 16, 2021·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Shervonne PoleonMichael D Twa

❮ Previous
Next ❯

Software Mentioned

SPSS Statistics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.